PTC Therapeutics Stock (NASDAQ: PTCT) stock price, news, charts, stock research, profile.
Open | $25.500 |
Close | $25.160 |
Volume / Avg. | 665.645K / 922.726K |
Day Range | 24.790 - 25.500 |
52 Wk Range | 17.530 - 59.840 |
Market Cap | $1.927B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 18.05% |
Days to Cover | 15.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PTC Therapeutics (NASDAQ: PTCT) through any online brokerage.
Other companies in PTC Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for PTC Therapeutics (NASDAQ: PTCT) was reported by Cantor Fitzgerald on Friday, April 12, 2024. The analyst firm set a price target for 45.00 expecting PTCT to rise to within 12 months (a possible 78.86% upside). 50 analyst firms have reported ratings in the last year.
The stock price for PTC Therapeutics (NASDAQ: PTCT) is $25.16 last updated April 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for PTC Therapeutics.
PTC Therapeutics’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for PTC Therapeutics.
PTC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.